769358

Astellas Pharma US Inc. — FEI 1000036852

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 27, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Northbrook, IL (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
294021 CFR 812.43(c)(4)(i)No investigation agreement statement of commitment
748021 CFR 312.50Ensuring compliance with plan and protocol